Elkar Solution for internal use, 300 mg / ml, 100 ml
Release form
Solution
Manufacturer country
Russia
Package quantity, pcs
one
Vacation conditions
Without recipe
Volume, ml.
100 ml
Elkar rr d / int.
taking 300mg / ml vial.
100ml
Name ENG
ELCAR
Clinical and pharmacological group
A drug that improves metabolism and energy supply of tissues
ATX code
Levocarnitine
Dosage
300mg / ml x 100ml
Structure
1 ml of oral solution contains: levocarnitine (carniphite) 300 mg.
Excipients: citric acid monohydrate 1.2 mg, methyl parahydroxybenzoate 0.5 mg, propyl parahydroxybenzoate 0.2 mg, purified water up to 1 ml.
Indications
The drug is used as part of complex therapy. intense physical activity and psychoemotional stress: to improve performance, endurance, reduce fatigue, including in the elderly during the period of rehabilitation after diseases and surgical interventions, injuries, including, to accelerate tissue regeneration complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function complex therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus) mild hyperthyroidism neurological manifestations in vascular, toxic and traumatic brain damage anorexia nervosa syndrome diseases accompanied by a lack of carnitine or its increased loss (myopathy, cardiomyopathy,mitochondrial diseases, hereditary diseases with concomitant mitochondrial insufficiency) to compensate for its deficiency as part of complex therapy in pediatric practice (treatment of children under 3 years of age under the supervision of a doctor): when nursing premature infants, newborns who have suffered a birth injury or asphyxiation children with a sluggish sucking reflex and low weight gain decreased muscle tone, with insufficient development of motor and mental functions, as well as with the aim of preventing these disorders in children of the risk group" with growth retardation and underweight in children and adolescents under 16 years of age. in adults in sports medicine and during intense training (during the training process when working out aerobic performance): to improve speed-strength indicators and coordination of movements,to increase muscle mass and reduce body fat mass, to prevent post-workout syndrome (accelerate recovery processes after physical exertion), with traumatic injuries in order to accelerate muscle regeneration.
Storage conditions and periods
In a dark place, at a temperature not exceeding 25 degrees.
Expiration date: 3 years
after opening - 2 months (at a temperature of 2-8 degrees)
INN / Active ingredient
Levocarnitine
Specifications
Release form
Solution
Manufacturer country
Russia
Package quantity, pcs
one
Vacation conditions
Without recipe
Volume, ml.
100 ml
Brand name
Peak Pharma
Components
measuring glass
The amount of the dosage form in the primary package
100 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Metabolic agent
Anatomical and therapeutic characteristics
A16AA01 Levocarnitine
Dosage form
Oral solution
Packaging
Box
Dosage (volume) of the substance in the preparation
levocarnitine 300 mg
Expiration date in days
1095
The target audience
Children
Package weight, g
one hundred
Category
:
Mental strain
,
Memory impairment
,
Neuroprotective agents
,
Nootropic drugs
Mode of application
:
The drug is used as part of complex therapy. Inside 30 minutes before meals, additionally diluted with liquid. < br> With prolonged physical and psycho-emotional stress: from 0.75 g (1/2 measuring spoon or 2.5 ml) 3 times a day to 2.25 g (1.5 measuring spoon or 7.5 ml) 2- 3 times a day. < br> With anorexia nervosa, as well as during the period of rehabilitation after illnesses and surgical interventions and injuries: 1.5 g (1 measuring spoon or 5 ml) 2 times a day. The course of treatment is within 1-2 months. < br> In the complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function: 0.375 g (1/4 measuring spoon or 1.25 ml) 2 times a day. The course of treatment is within 1-1.5 months. < br> For the treatment of skin diseases: 0.75 g each (1/2 measuring spoon or 2.5 ml). The course of treatment is within 2-4 weeks. < br> With mild hyperthyroidism: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> For vascular, toxic and traumatic brain lesions: 0.75 g (1/2 measuring spoon or 2.5 ml) per day. The course of treatment is within 3-5 days. If necessary, a second course is prescribed after 12-14 days. < br> For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency): up to 50-100 mg / kg (2-5 drops / kg) body weight with a frequency of taking 2-3 times a day. The course of treatment is within 3-4 months. < br> Children are prescribed in the form of an additive to sweet dishes (jelly, compote, juices): for children under 3 years of age, the dose is determined by the attending physician from 3 to 6 years old - in a single dose of 0.1 g (5 drops) 2-3 times a day,in a daily dose of 0.2-0.3 g (11-16 drops). The course of treatment is 1 month children from 6 to 12 years old are prescribed in a single dose of 0.2-0.3 g (11-16 drops) 2-3 times a day, in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month. < br> With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month. < br> With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month. < br> With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5-7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5-7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.
Information on technical characteristics, delivery set, country of manufacture "